Does Blue Cross Blue Shield of Texas Cover Ozempic?
The verdict
Conditional on most plans
BCBS of Texas (an HCSC company) covers Ozempic for type 2 diabetes with prior authorization across commercial, ACA, and Medicare Advantage lines. HCSC also operates BCBS plans in Illinois, New Mexico, Oklahoma, and Montana — meaning PA infrastructure and criteria may be shared across HCSC affiliates, unlike independent BCBS affiliates such as BCBS Alabama or BCBS Minnesota. It is not covered for off-label weight-loss use. Texas Medicaid is administered through separate Star MCO plans and is not part of BCBS Texas's commercial formulary. Formulary details not publicly confirmed at drug level — verify on BCBS Texas drug lookup.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield of Texas using your member ID.
Key facts
BCBS of Texas is operated by Health Care Service Corporation (HCSC), which also runs BCBS plans in Illinois, New Mexico, Oklahoma, and Montana — meaning PA infrastructure for Ozempic may be shared across all five HCSC affiliates.
Health Care Service Corporation (HCSC) corporate information
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D adults — not for weight loss.
FDA drug labeling, Ozempic (semaglutide injection)
The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) under Medicare is $274 per 30-day supply, effective January 1, 2027.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield of Texas covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage: BCBS of Texas participates in the Texas Medicare Advantage market; Ozempic is covered for type 2 diabetes with prior authorization. The 2026 Part D $2,100 out-of-pocket cap limits annual beneficiary exposure. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply effective January 1, 2027. Medicare enrollees cannot use the NovoCare savings card (federal anti-kickback rules). Ozempic is not covered for weight loss on any Medicare Advantage plan — off-label weight-loss use is statutorily excluded from Medicare Part D.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: BCBS of Texas covers Ozempic for type 2 diabetes with prior authorization and standard metformin step-therapy via HCSC's PA infrastructure. As an HCSC company, PA criteria may be shared with BCBS Illinois, BCBS New Mexico, BCBS Oklahoma, and BCBS Montana — though this shared infrastructure is likely but not confirmed in a primary published document. Verify on BCBS Texas's drug lookup. Not covered for off-label weight loss. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150/28-day supply); not available to Medicare or Medicaid enrollees. ACA/Individual: covered for T2D with PA; ACA plans generally exclude GLP-1s for weight loss. Medicaid: BCBS Texas is not a Texas Medicaid MCO; Texas Medicaid Star plans (Molina, Centene/Superior, Community Health Choice, etc.) cover Ozempic for T2D separately through the state's managed-care program.
The 2 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 2 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing). NovoCare self-pay: ~$199/month intro (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial/Employer: tier-based cost-share via HCSC platform; specific tier and copay not publicly published — verify on BCBS Texas's drug lookup. Medicare Advantage: cost-share per plan design; $2,100 OOP cap 2026; IRA Maximum Fair Price $274/30-day effective January 1, 2027. Texas Medicaid (via Star MCO plans): nominal $0–$4 typical for covered T2D use.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare Advantage, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Specific tier and cost-share for BCBS Texas commercial plans are not publicly confirmed at the drug level. Verify on BCBS Texas's drug lookup or by calling member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use BCBS Texas's drug lookup tool to confirm formulary status and PA requirements
Visit bcbstx.com and use the drug-lookup or formulary tool with your member ID to confirm Ozempic's tier, any prior-authorization requirements, and step-therapy criteria for your specific commercial or Medicare Advantage plan. Tier and copay are not published at the drug level in publicly available documents.
- 2
Have your prescriber submit the prior authorization for type 2 diabetes
The PA requires a documented T2D diagnosis (ICD-10 E11.x) and evidence of metformin use (or a documented medical reason metformin is contraindicated or not tolerated). PA submissions go through HCSC's platform, which may share criteria with other HCSC-affiliated BCBS plans. The clinical indication must be type 2 diabetes; a weight-management indication will not support PA approval under any BCBS Texas plan.
- 3
Check NovoCare savings card eligibility if you have commercial coverage
If you have a BCBS Texas commercial or employer-sponsored plan and a confirmed T2D diagnosis, visit NovoCare.com to enroll in the Ozempic Savings Card, which may reduce your out-of-pocket cost to as little as $25 per fill (max $150/28-day supply). This card is not available to Medicare Advantage or Medicaid enrollees. If you have Texas Medicaid through a Star MCO plan, contact that plan directly for your cost-share.
Options if Blue Cross Blue Shield of Texas won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet approved for type 2 diabetes. Covered for T2D with PA on most plans; also subject to the IRA Maximum Fair Price of $274/30-day for Medicare patients effective January 1, 2027. Verify tier on BCBS Texas's drug lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as oral step therapy before Ozempic PA. Often available at a lower cost-share tier on HCSC-platform BCBS formularies.
Wegovy (semaglutide 2.4 mg)
On-label for weight management. BCBS Texas's coverage for Wegovy weight loss is not publicly confirmed — ACA plans generally exclude GLP-1s for weight loss; employer-plan coverage depends on whether the employer purchased the anti-obesity benefit. These are different drugs for coverage purposes.
Compounded semaglutide (weight-loss seekers only)
For patients seeking semaglutide for weight management who are denied under BCBS Texas, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. BCBS of Texas does not cover Ozempic for weight loss under any line of business. Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction in T2D patients with known heart disease — not for weight management. Off-label weight-loss use is not a covered indication under any HCSC-operated plan. ACA plans administered by BCBS Texas generally exclude GLP-1 weight-loss drugs entirely; commercial employer plans may cover Wegovy for weight loss if the employer purchased the anti-obesity benefit, but that does not extend to Ozempic.
Yes. BCBS of Texas covers Ozempic for type 2 diabetes with prior authorization on its commercial, ACA, and Medicare Advantage plans. PA requires a documented T2D diagnosis and evidence of metformin step-therapy via HCSC's PA platform. Formulary tier and copay are not publicly confirmed at the drug level — verify on BCBS Texas's drug lookup or by calling member services.
Texas Medicaid (Medicaid Star program) covers Ozempic for type 2 diabetes through separate managed-care organizations — not through BCBS Texas. Texas Star MCOs include Molina Healthcare of Texas, Superior Health Plan (Centene), Community Health Choice, and others. If you have Texas Medicaid, contact your Star MCO directly for your drug formulary and PA requirements. BCBS Texas is a commercial insurer, not a Texas Medicaid contractor.
Likely similar but not confirmed as identical. Both BCBS Texas and BCBS Illinois are operated by Health Care Service Corporation (HCSC), which shares PA infrastructure across its five BCBS affiliates (TX, IL, NM, OK, MT). In practice, T2D patients submitting PA for Ozempic through either BCBS TX or BCBS IL will encounter the same core criteria — T2D diagnosis plus metformin step-therapy — but specific requirements should be verified on each plan's own drug lookup tool, as HCSC plan-level variation is possible.
Yes, if you have a BCBS Texas commercial or employer-sponsored plan and a confirmed T2D diagnosis. The NovoCare Ozempic Savings Card may reduce your cost to as little as $25 per fill (max $150/28-day supply). The card is not available to Medicare Advantage or Medicaid enrollees — federal anti-kickback rules exclude government program beneficiaries. Verify current eligibility and terms at NovoCare.com.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS of Arizona Cover Wegovy? 2026 Guide | Curex
BCBS of Arizona covers Wegovy only where your employer opted in; formulary not published. Verify via drug-lookup and confirm with HR first.
Read moreDoes Blue Cross Blue Shield of Illinois Cover Wegovy? | Curex
BCBS Illinois (HCSC) covers Wegovy only where your employer opts in. ACA plans exclude it. Formulary not public — verify on your plan's drug-lookup tool.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
BCBS of Texas does not cover Ozempic for weight loss. For Texas patients seeking semaglutide for weight management, Curex offers compounded semaglutide from $49/mo at getcurex.com/cl/glp — no BCBS Texas prior authorization required, no insurance needed. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield of Texas before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.